Artículos relacionados a Antiviral Drug Strategies (Methods & Principles...

Antiviral Drug Strategies (Methods & Principles in Medicinal Chemistry) - Tapa dura

 
9783527326969: Antiviral Drug Strategies (Methods & Principles in Medicinal Chemistry)
Ver todas las copias de esta edición ISBN.
 
 
BY FOCUSING ON GENERAL MOLECULAR MECHANISMS OF ANTIVIRAL DRUGS RATHER THAN THERAPIES FOR INDIVIDUAL VIRUSES, THIS READY REFERENCE PROVIDES THE CRITICAL KNOWLEDGE NEEDED TO DEVELOP ENTIRELY NOVEL THERAPEUTICS AND TO TARGET NEW VIRUSES. IT BEGINS WITH A GENERAL DISCUSSION OF ANTIVIRAL STRATEGIES, FOLLOWED BY A BROAD SURVEY OF KNOWN VIRAL TARGETS, SUCH AS REVERSE TRANSCRIPTASES, PROTEASES, NEURAMINIDASES, RNA POLYMERASES, HELICASES AND PRIMASES, AS WELL AS THEIR KNOWN INHIBITORS. THE FINAL SECTION CONTAINS SEVERAL CASES STUDIES OF RECENT SUCCESSFUL ANTIVIRAL DRUG DEVELOPMENT. EDITED BY ERIK DE CLERCQ, THE WORLD AUTHORITY ON SMALL MOLECULE ANTIVIRAL DRUGS, WHO HAS DEVELOPED MORE NEW ANTIVIRALS THAN ANYONE ELSE.

"Sinopsis" puede pertenecer a otra edición de este libro.

Críticas:
"Overall, the book is a clear success and represents an excellent and valuable treatise on current antiviral drug strategies. It is a must for all medicinal chemists interested in the field of antiviral chemotherapy, and it would be a good acquisition for both institutional and personal libraries, alike." (ChemMedChem, 2012)
Reseña del editor:
By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development. Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.

"Sobre este título" puede pertenecer a otra edición de este libro.

  • EditorialBlackwell Verlag GmbH
  • Año de publicación2011
  • ISBN 10 3527326960
  • ISBN 13 9783527326969
  • EncuadernaciónTapa dura
  • Número de edición1
  • Número de páginas426
  • EditorDe Clercq Erik

Comprar usado

Condición: Aceptable
Connecting readers with great books... Ver este artículo

Gastos de envío: EUR 3,46
A Estados Unidos de America

Destinos, gastos y plazos de envío

Añadir al carrito

Los mejores resultados en AbeBooks

Imagen de archivo

Publicado por Wiley-VCH (2011)
ISBN 10: 3527326960 ISBN 13: 9783527326969
Antiguo o usado Tapa dura Cantidad disponible: 1
Librería:
HPB-Red
(Dallas, TX, Estados Unidos de America)

Descripción Hardcover. Condición: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!. Nº de ref. del artículo: S_343448401

Más información sobre este vendedor | Contactar al vendedor

Comprar usado
EUR 200,37
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,46
A Estados Unidos de America
Destinos, gastos y plazos de envío